| Primary information |
|---|
| sequence ID | Seq_1995 |
| Peptide sequence | ETLPPDLLRGPLQL |
| CancerPDF_ID | CancerPDF_ID4789, CancerPDF_ID10198, |
| PMID | 24982608,21805675 |
| Protein Name | Leucine-rich alpha-2-glycoprotein,Leucine-rich alpha-2-glycoprotein |
| UniprotKB Entry Name | A2GL_HUMAN,A2GL_HUMAN |
| Fluid | Urine,Urine |
| M/Z | NA,1561.8906 |
| Charge | NA,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | Nano-LC-MS,MALDI-TOF |
| Peptide Identification technique | MS/MS,MALDI-TOF-MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | 0.01,1 |
| CancerPDF_ID | CancerPDF_ID4789, CancerPDF_ID10198, |
| p-Value | NA,NA |
| Software | "GPM search engine, MASCOT",NA |
| Length | 14,14 |
| Cancer Type | Ovarian cancer,Muscle-invasive bladder cancer |
| Database | IPI 3.71 Human Database ,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 6 Ovarian cancer patients and 6 normal individuals,751 bladder cancer and 127 control |
| Regulation | Uniquely present in case of urine of ovarian cancer patients,Differentially expressed between cancer vs normal samples |
| Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |